HEADER TRANSFERASE 12-SEP-18 6HMB TITLE STRUCTURE OF PROTEIN KINASE CK2 CATALYTIC SUBUNIT (ISOFORM CK2ALPHA'; TITLE 2 CSNK2A2 GENE PRODUCT) IN COMPLEX WITH THE INHIBITOR CX-4945 TITLE 3 (SILMITASERTIB) COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASEIN KINASE II SUBUNIT ALPHA'; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CK II ALPHA'; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CSNK2A2, CK2A2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE CK2, CASEIN KINASE 2, CATALYTIC SUBUNIT CK2ALPHA', KEYWDS 2 CSNK2A2, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.NIEFIND,D.LINDENBLATT,V.M.APPLEGATE,J.JOSE,M.LE BORGNE REVDAT 4 15-MAY-24 6HMB 1 REMARK REVDAT 3 09-OCT-19 6HMB 1 JRNL REVDAT 2 28-AUG-19 6HMB 1 REMARK REVDAT 1 27-MAR-19 6HMB 0 JRNL AUTH D.LINDENBLATT,A.NICKELSEN,V.M.APPLEGATE,J.HOCHSCHERF, JRNL AUTH 2 B.WITULSKI,Z.BOUAZIZ,C.MARMINON,M.BRETNER,M.LE BORGNE, JRNL AUTH 3 J.JOSE,K.NIEFIND JRNL TITL DIACRITIC BINDING OF AN INDENOINDOLE INHIBITOR BY CK2 ALPHA JRNL TITL 2 PARALOGS EXPLORED BY A RELIABLE PATH TO ATOMIC RESOLUTION JRNL TITL 3 CK2 ALPHA ' STRUCTURES. JRNL REF ACS OMEGA V. 4 5471 2019 JRNL REFN ESSN 2470-1343 JRNL PMID 31559376 JRNL DOI 10.1021/ACSOMEGA.8B03415 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.HOCHSCHERF,D.LINDENBLATT,B.WITULSKI,R.BIRUS,D.AICHELE, REMARK 1 AUTH 2 C.MARMINON,Z.BOUAZIZ,M.LE BORGNE,J.JOSE,K.NIEFIND REMARK 1 TITL UNEXPECTED BINDING MODE OF A POTENT INDENO[1,2-B]INDOLE-TYPE REMARK 1 TITL 2 INHIBITOR OF PROTEIN KINASE CK2 REVEALED BY COMPLEX REMARK 1 TITL 3 STRUCTURES WITH THE CATALYTIC SUBUNIT CK2ALPHA AND ITS REMARK 1 TITL 4 PARALOG CK2ALPHA' REMARK 1 REF PHARMACEUTICALS (BASEL) V. 10 2017 REMARK 1 REFN ESSN 1424-8247 REMARK 1 PMID 29236079 REMARK 1 DOI 10.3390/PH10040098 REMARK 1 REFERENCE 2 REMARK 1 AUTH I.ERMAKOVA,B.BOLDYREFF,O.G.ISSINGER,K.NIEFIND REMARK 1 TITL CRYSTAL STRUCTURE OF A C-TERMINAL DELETION MUTANT OF HUMAN REMARK 1 TITL 2 PROTEIN KINASE CK2 CATALYTIC SUBUNIT. REMARK 1 REF J. MOL. BIOL. V. 330 925 2003 REMARK 1 REFN ISSN 0022-2836 REMARK 1 PMID 12860116 REMARK 2 REMARK 2 RESOLUTION. 1.04 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.13_2998: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.04 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.59 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.930 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 187814 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.135 REMARK 3 R VALUE (WORKING SET) : 0.134 REMARK 3 FREE R VALUE : 0.146 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1877 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.6084 - 2.4449 0.99 14433 145 0.1425 0.1633 REMARK 3 2 2.4449 - 1.9406 0.99 14451 146 0.1254 0.1106 REMARK 3 3 1.9406 - 1.6953 0.99 14486 146 0.1151 0.1302 REMARK 3 4 1.6953 - 1.5403 0.99 14450 146 0.1064 0.1208 REMARK 3 5 1.5403 - 1.4299 0.99 14454 147 0.1062 0.1245 REMARK 3 6 1.4299 - 1.3456 0.99 14388 145 0.1138 0.1356 REMARK 3 7 1.3456 - 1.2782 0.98 14322 145 0.1215 0.1281 REMARK 3 8 1.2782 - 1.2226 0.98 14169 142 0.1356 0.1564 REMARK 3 9 1.2226 - 1.1755 0.98 14256 144 0.1484 0.1708 REMARK 3 10 1.1755 - 1.1350 0.98 14148 143 0.1705 0.1979 REMARK 3 11 1.1350 - 1.0995 0.97 14216 143 0.1853 0.2016 REMARK 3 12 1.0995 - 1.0680 0.97 14112 143 0.2151 0.2380 REMARK 3 13 1.0680 - 1.0399 0.96 14052 142 0.2506 0.2597 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.090 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.200 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.53 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3110 REMARK 3 ANGLE : 1.180 4210 REMARK 3 CHIRALITY : 0.087 424 REMARK 3 PLANARITY : 0.008 549 REMARK 3 DIHEDRAL : 19.178 1198 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6HMB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-SEP-18. REMARK 100 THE DEPOSITION ID IS D_1200011547. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 187923 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.040 REMARK 200 RESOLUTION RANGE LOW (A) : 32.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : 0.07100 REMARK 200 FOR THE DATA SET : 11.7500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.04 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.40 REMARK 200 R MERGE FOR SHELL (I) : 1.28600 REMARK 200 R SYM FOR SHELL (I) : 1.28600 REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO PHASING REMARK 200 SOFTWARE USED: ARCIMBOLDO REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 180 MICROLITER ENZYME STOCK SOLUTION REMARK 280 (6 MG/ML IN 500 MM NACL, 25 MM TRIS/HCL, PH 8.5) WERE MIXED AND REMARK 280 INCUBATED WITH 20 MIKROLITER OF A STOCK SOLUTION OF THE REMARK 280 INHIBITOR 4B0 (10 MM 4B0 IN DMSO). 20 MICROLITERS OF THE REMARK 280 RESULTING SOLUTION WERE MIXED WITH 10 MICROLITERS OF RESERVOIR REMARK 280 SOLUTION (900 MM LICL, 28 % (W/V) PEG 6000, 100 MM TRIS/HCL, PH REMARK 280 8.5) IN EACH WELL OF A CRYSTALLIZATION PLATE. A SINGLE MACROSEED, REMARK 280 GROWN UNDER THE SAME CONDITIONS, WAS ADDED TO EACH DROPLET OF REMARK 280 THE PLATE. THE DROPLETS WERE EQUILIBRATED AT 293.15 K USING THE REMARK 280 SITTING DROP VARIANT OF THE VAPOR DIFFUSION METHOD. THIS REMARK 280 PROCEDURE GENERATED LARGE SINGLE CRYSTALS OF A CK2ALPHA'/4B0 REMARK 280 COMPLEX. AFTERWARDS, THE INHIBITOR 4B0 WAS EXCHANGED AGAINST CX- REMARK 280 4945 BY AN EXTENSIVE SOAKING PROCEDURE OF SEVERAL STEPS., VAPOR REMARK 280 DIFFUSION, SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14800 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -13 REMARK 465 GLY A -12 REMARK 465 SER A -11 REMARK 465 SER A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 SER A -3 REMARK 465 GLN A -2 REMARK 465 ASP A -1 REMARK 465 PRO A 0 REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 GLY A 3 REMARK 465 PRO A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 PRO A 335 REMARK 465 SER A 336 REMARK 465 ALA A 337 REMARK 465 ASP A 338 REMARK 465 ASN A 339 REMARK 465 ALA A 340 REMARK 465 VAL A 341 REMARK 465 LEU A 342 REMARK 465 SER A 343 REMARK 465 SER A 344 REMARK 465 GLY A 345 REMARK 465 LEU A 346 REMARK 465 THR A 347 REMARK 465 ALA A 348 REMARK 465 ALA A 349 REMARK 465 ARG A 350 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 138 CG - SD - CE ANGL. DEV. = -11.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 157 42.22 -149.53 REMARK 500 ASP A 176 78.46 58.24 REMARK 500 ALA A 194 156.91 65.52 REMARK 500 MET A 209 53.91 -92.20 REMARK 500 HIS A 235 72.06 -106.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 947 DISTANCE = 6.33 ANGSTROMS REMARK 525 HOH A 948 DISTANCE = 6.48 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 407 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 408 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 409 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 410 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 411 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 412 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3NG A 413 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6HMC RELATED DB: PDB REMARK 900 6HMC CONTAINS THE SAME PROTEIN WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 6HMD RELATED DB: PDB REMARK 900 6HMD CONTAINS THE SAME PROTEIN WITH A DIFFERENT INHIBITOR. REMARK 900 RELATED ID: 6HMQ RELATED DB: PDB REMARK 900 6HMQ CONTAINS THE SAME PROTEIN WITH A DIFFERENT INHIBITOR. DBREF 6HMB A 1 350 UNP P19784 CSK22_HUMAN 1 350 SEQADV 6HMB MET A -13 UNP P19784 INITIATING METHIONINE SEQADV 6HMB GLY A -12 UNP P19784 EXPRESSION TAG SEQADV 6HMB SER A -11 UNP P19784 EXPRESSION TAG SEQADV 6HMB SER A -10 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -9 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -8 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -7 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -6 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -5 UNP P19784 EXPRESSION TAG SEQADV 6HMB HIS A -4 UNP P19784 EXPRESSION TAG SEQADV 6HMB SER A -3 UNP P19784 EXPRESSION TAG SEQADV 6HMB GLN A -2 UNP P19784 EXPRESSION TAG SEQADV 6HMB ASP A -1 UNP P19784 EXPRESSION TAG SEQADV 6HMB PRO A 0 UNP P19784 EXPRESSION TAG SEQADV 6HMB SER A 336 UNP P19784 CYS 336 ENGINEERED MUTATION SEQRES 1 A 364 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER GLN ASP SEQRES 2 A 364 PRO MET PRO GLY PRO ALA ALA GLY SER ARG ALA ARG VAL SEQRES 3 A 364 TYR ALA GLU VAL ASN SER LEU ARG SER ARG GLU TYR TRP SEQRES 4 A 364 ASP TYR GLU ALA HIS VAL PRO SER TRP GLY ASN GLN ASP SEQRES 5 A 364 ASP TYR GLN LEU VAL ARG LYS LEU GLY ARG GLY LYS TYR SEQRES 6 A 364 SER GLU VAL PHE GLU ALA ILE ASN ILE THR ASN ASN GLU SEQRES 7 A 364 ARG VAL VAL VAL LYS ILE LEU LYS PRO VAL LYS LYS LYS SEQRES 8 A 364 LYS ILE LYS ARG GLU VAL LYS ILE LEU GLU ASN LEU ARG SEQRES 9 A 364 GLY GLY THR ASN ILE ILE LYS LEU ILE ASP THR VAL LYS SEQRES 10 A 364 ASP PRO VAL SER LYS THR PRO ALA LEU VAL PHE GLU TYR SEQRES 11 A 364 ILE ASN ASN THR ASP PHE LYS GLN LEU TYR GLN ILE LEU SEQRES 12 A 364 THR ASP PHE ASP ILE ARG PHE TYR MET TYR GLU LEU LEU SEQRES 13 A 364 LYS ALA LEU ASP TYR CYS HIS SER LYS GLY ILE MET HIS SEQRES 14 A 364 ARG ASP VAL LYS PRO HIS ASN VAL MET ILE ASP HIS GLN SEQRES 15 A 364 GLN LYS LYS LEU ARG LEU ILE ASP TRP GLY LEU ALA GLU SEQRES 16 A 364 PHE TYR HIS PRO ALA GLN GLU TYR ASN VAL ARG VAL ALA SEQRES 17 A 364 SER ARG TYR PHE LYS GLY PRO GLU LEU LEU VAL ASP TYR SEQRES 18 A 364 GLN MET TYR ASP TYR SER LEU ASP MET TRP SER LEU GLY SEQRES 19 A 364 CYS MET LEU ALA SER MET ILE PHE ARG ARG GLU PRO PHE SEQRES 20 A 364 PHE HIS GLY GLN ASP ASN TYR ASP GLN LEU VAL ARG ILE SEQRES 21 A 364 ALA LYS VAL LEU GLY THR GLU GLU LEU TYR GLY TYR LEU SEQRES 22 A 364 LYS LYS TYR HIS ILE ASP LEU ASP PRO HIS PHE ASN ASP SEQRES 23 A 364 ILE LEU GLY GLN HIS SER ARG LYS ARG TRP GLU ASN PHE SEQRES 24 A 364 ILE HIS SER GLU ASN ARG HIS LEU VAL SER PRO GLU ALA SEQRES 25 A 364 LEU ASP LEU LEU ASP LYS LEU LEU ARG TYR ASP HIS GLN SEQRES 26 A 364 GLN ARG LEU THR ALA LYS GLU ALA MET GLU HIS PRO TYR SEQRES 27 A 364 PHE TYR PRO VAL VAL LYS GLU GLN SER GLN PRO SER ALA SEQRES 28 A 364 ASP ASN ALA VAL LEU SER SER GLY LEU THR ALA ALA ARG HET EDO A 401 10 HET EDO A 402 10 HET EDO A 403 10 HET EDO A 404 10 HET EDO A 405 10 HET EDO A 406 10 HET EDO A 407 10 HET EDO A 408 10 HET EDO A 409 10 HET EDO A 410 10 HET CL A 411 1 HET CL A 412 1 HET 3NG A 413 36 HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETNAM 3NG 5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8- HETNAM 2 3NG CARBOXYLIC ACID HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO 10(C2 H6 O2) FORMUL 12 CL 2(CL 1-) FORMUL 14 3NG C19 H12 CL N3 O2 FORMUL 15 HOH *448(H2 O) HELIX 1 AA1 SER A 21 ASP A 26 1 6 HELIX 2 AA2 TYR A 27 HIS A 30 5 4 HELIX 3 AA3 LYS A 75 LEU A 89 1 15 HELIX 4 AA4 ASP A 121 TYR A 126 1 6 HELIX 5 AA5 THR A 130 LYS A 151 1 22 HELIX 6 AA6 LYS A 159 HIS A 161 5 3 HELIX 7 AA7 ASP A 176 ALA A 180 5 5 HELIX 8 AA8 SER A 195 LYS A 199 5 5 HELIX 9 AA9 GLY A 200 VAL A 205 1 6 HELIX 10 AB1 TYR A 212 ARG A 229 1 18 HELIX 11 AB2 ASP A 238 GLY A 251 1 14 HELIX 12 AB3 GLY A 251 HIS A 263 1 13 HELIX 13 AB4 ASP A 267 ILE A 273 5 7 HELIX 14 AB5 ARG A 281 ILE A 286 5 6 HELIX 15 AB6 ASN A 290 VAL A 294 5 5 HELIX 16 AB7 SER A 295 LEU A 306 1 12 HELIX 17 AB8 ASP A 309 ARG A 313 5 5 HELIX 18 AB9 THR A 315 GLU A 321 1 7 HELIX 19 AC1 HIS A 322 TYR A 324 5 3 HELIX 20 AC2 PHE A 325 GLN A 332 1 8 SHEET 1 AA1 6 GLY A 35 ASN A 36 0 SHEET 2 AA1 6 LEU A 98 LYS A 103 1 O THR A 101 N GLY A 35 SHEET 3 AA1 6 PRO A 110 GLU A 115 -1 O VAL A 113 N ILE A 99 SHEET 4 AA1 6 ARG A 65 LEU A 71 -1 N LYS A 69 O LEU A 112 SHEET 5 AA1 6 SER A 52 ASN A 59 -1 N PHE A 55 O VAL A 68 SHEET 6 AA1 6 TYR A 40 ARG A 48 -1 N VAL A 43 O GLU A 56 SHEET 1 AA2 2 ILE A 153 MET A 154 0 SHEET 2 AA2 2 GLU A 181 PHE A 182 -1 O GLU A 181 N MET A 154 SHEET 1 AA3 2 VAL A 163 ASP A 166 0 SHEET 2 AA3 2 LYS A 171 LEU A 174 -1 O LYS A 171 N ASP A 166 CISPEP 1 GLU A 231 PRO A 232 0 -11.38 SITE 1 AC1 10 LEU A 86 LEU A 89 ARG A 90 GLY A 91 SITE 2 AC1 10 ILE A 95 ILE A 96 LYS A 97 LEU A 98 SITE 3 AC1 10 HOH A 681 HOH A 723 SITE 1 AC2 9 ASN A 119 THR A 120 ASP A 121 PHE A 122 SITE 2 AC2 9 PRO A 160 VAL A 163 MET A 164 ILE A 165 SITE 3 AC2 9 EDO A 406 SITE 1 AC3 8 LEU A 42 ILE A 70 GLU A 318 GLU A 321 SITE 2 AC3 8 HIS A 322 HOH A 565 HOH A 652 HOH A 799 SITE 1 AC4 7 ASP A 133 PHE A 136 TYR A 137 HIS A 167 SITE 2 AC4 7 LYS A 170 HOH A 524 HOH A 639 SITE 1 AC5 8 PHE A 122 LYS A 123 PRO A 160 PHE A 198 SITE 2 AC5 8 GLU A 231 HOH A 707 HOH A 712 HOH A 770 SITE 1 AC6 5 ASN A 119 ASP A 121 HIS A 161 MET A 164 SITE 2 AC6 5 EDO A 402 SITE 1 AC7 9 ARG A 230 PHE A 233 PHE A 234 HIS A 235 SITE 2 AC7 9 ARG A 245 HOH A 536 HOH A 695 HOH A 771 SITE 3 AC7 9 HOH A 938 SITE 1 AC8 6 ARG A 81 ARG A 156 LEU A 179 CL A 412 SITE 2 AC8 6 HOH A 513 HOH A 564 SITE 1 AC9 5 GLU A 188 ASN A 190 GLN A 208 HOH A 741 SITE 2 AC9 5 HOH A 851 SITE 1 AD1 5 ASP A 157 LYS A 159 ALA A 194 SER A 195 SITE 2 AD1 5 HOH A 584 SITE 1 AD2 4 ARG A 230 HOH A 536 HOH A 731 HOH A 818 SITE 1 AD3 3 ARG A 156 ASN A 190 EDO A 408 SITE 1 AD4 17 LEU A 46 GLY A 47 ARG A 48 VAL A 67 SITE 2 AD4 17 LYS A 69 PHE A 114 GLU A 115 TYR A 116 SITE 3 AD4 17 ILE A 117 HIS A 161 MET A 164 ILE A 175 SITE 4 AD4 17 ASP A 176 HOH A 582 HOH A 624 HOH A 775 SITE 5 AD4 17 HOH A 794 CRYST1 46.350 47.720 50.420 113.08 90.28 90.85 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021575 0.000319 0.000252 0.00000 SCALE2 0.000000 0.020958 0.008936 0.00000 SCALE3 0.000000 0.000000 0.021561 0.00000